The St. Jude Medical Infinity™ Deep Brain Stimulation (DBS) system with directional lead technology is designed to help patients with Parkinson’s disease or essential tremor gain control of their ...

HealthDay News — Subthalamic deep brain stimulation (DBS) is an effective long-term therapy for Parkinson disease (PD), according to a study published online September 15 in JAMA Neurology.

Abbott Laboratories (NYSE:ABT) received FDA approval to launch the Liberta RC DBS system, the world’s smallest rechargeable deep brain stimulation (DBS) device with remote programming, to treat people ...

The US Food and Drug Administration (FDA) has approved a new software upgrade for Abbott's Infinity deep-brain stimulation (DBS) system used in patients with Parkinson's disease and essential tremor, ...

The US Food and Drug Administration (FDA) has approved Medtronic's technologically advanced deep brain stimulation (DBS) system designed to more precisely target motor symptoms in Parkinson's disease, ...

Boston Scientific Corporation BSX has received CE Mark approval for use of the GUIDE™ DBS System, the world's first deep brain stimulation (DBS) visualization system. GUIDE DBS provides clinicians ...

Medtronic plc MDT received the CE Mark for its SenSight directional lead for the treatment of system symptoms associated with movement disorders and epilepsy. SenSight is currently the only available ...